Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-12-12

Clinical Trial Update: COL Immunotherapy Before Radiochimio + Ipilimumab [NA]

View source ↗

Summary

A completed clinical trial evaluating COL immunotherapy before radioimmunotherapy and ipilimumab in cervical cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • COL Immunotherapy
  • Ipilimumab (Yervoy) (ipilimumab)

Snippet

Sponsor: ARCAGY/ GINECO GROUP | Conditions: Cervix Cancer | NA | Status: COMPLETED